Cannabis Law Report

FEBRUARY 26, 2022

The organization has, they say, ……evaluated patient access, affordability, equity, and product safety. With a decline in legislative improvements in state medical cannabis programs, millions of patients are left with limited or no access,” ASA Executive Director Debbie Churgai said. “It

Access 98

Access Law Patients Programs 98

Cannabis Law Report

APRIL 15, 2022

11 April 2022. On Friday, April 1, 2022, the House of Representatives passed the Marijuana Opportunity, Reinvestment, and Expungement (MORE) Act for the second time in two years, with 220 votes in favor and 204 votes in opposition. by Remington Angelle and Michael Schwegler. McGlinchey Stafford.

Marijuana 52

Marijuana Banking Research and Development Legislation 52

Cannabis Law Report

NOVEMBER 29, 2021

Numerous states in 2021 also enacted legislation expanding medical cannabis access and stimulating greater diversity among licensed marijuana businesses. “As Public and political support for these legislative changes in marijuana laws will continue growing in 2022 and beyond. The law took effect August 1, 2021.

Legislation 98

Legislation Patients Retail Access 98

Cannabis Law Report

MAY 30, 2021

Multiple state lawmakers told City Pulse this week that Linder has been shopping legislative amendments for months that aim to reel back existing plant and patient allowances for medical marijuana caregivers and also require that their products be tested at a licensed laboratory. It’s the guy who is blowing out 100, 200 or 300 lights.

Patients 105

Patients Cannabis Retail Safety 105

Cannabis Law Report

MAY 25, 2022

For the third category, the Court recognized transportation employers, federal government contractors, and recipients of federal grants as employers with such statutory obligations under federal law. The plaintiff, Cristina Barbuto, used small quantities of medicinal marijuana as treatment for her Crohn’s disease. 2] Barbuto , p.

Policy 52

Policy Safety Law Patients 52

Cannabis Law Report

MAY 19, 2022

FDA states it has serious safety concerns with delta-8 THC. FDA states it has received 104 reports of adverse events in patients who consumed delta-8 THC products between December 1, 2020 and February 28, 2022. FDA considers delta-8 THC to pose serious health and safety risks. FDA Warning Letters.

THC 52

THC CBD Food Pets 52

Veriheal

JANUARY 5, 2022

Young and Joyce also question the federal government’s motives, stating, “To be clear, we do not negate the benefit of traditional therapies, but question why the federal government continues to bar access to innovative, proven—and in many cases—safer alternatives.” The Congressional Cannabis Caucus is a group of members of the U.S.

Legislation 52

Legislation Cannabis Therapy Access 52

Cannabis Law Report

MAY 6, 2022

May 6, 2022. The FDA explains it is monitoring the selling of CBD and Delta-8 THC products out of a growing safety concern. COAs are generally issued by accredited laboratories and many states require sellers to include COAs with each cannabis or CBD product. Delta-8 is known to be successful in many cancer treatments.”.

THC 52

THC CBD Media Food 52

Cannabis Law Report

OCTOBER 20, 2019

She has also served as the past chair of ABA National Conference of Specialized Court Judges; the President of the American Judge’s Association and the Colorado Women’s Bar Association Foundation, and, as a National Highway Traffic Safety Administration (NHTSA) Judicial Outreach Liaison. billion by 2022 from $3.1 billion in 2016.

Marijuana 45

Marijuana Pharmaceutical Chronic Pain Research and Development 45

Greenspoon Marder Cannabis Law Group Blog

APRIL 19, 2021

With the passage of House Bill 19-1230 allowing for state-licensed hospitality licenses, Denver needed to modify its marijuana consumption program to comply with the new state law. The above bill repeals I-300 in its entirety and below is a summary of the ordinance set to replace it.

Marijuana 76

Marijuana Consumption Retail Business 76

Cannabis Law Report

MAY 16, 2022

2616 STATE OF NEW JERSEY 220th LEGISLATURE. INTRODUCED MAY 12, 2022. Expands implied consent law to include blood testing; establishes per se standard for driving under influence of marijuana and certain controlled dangerous substances. (b) The new measure ( S2616 ) would expand that to blood testing. SENATE, No.

Consumption 52

Consumption Legislation Programs Concentrates 52